These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34504297)

  • 1. Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma.
    Dong C; Cesarano A; Bombaci G; Reiter JL; Yu CY; Wang Y; Jiang Z; Zaid MA; Huang K; Lu X; Walker BA; Perna F; Liu Y
    Oncogene; 2021 Oct; 40(42):6130-6138. PubMed ID: 34504297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer.
    Dong C; Reiter JL; Dong E; Wang Y; Lee KP; Lu X; Liu Y
    JCO Clin Cancer Inform; 2022 Feb; 6():e2100124. PubMed ID: 35148169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma.
    Perumal D; Imai N; Laganà A; Finnigan J; Melnekoff D; Leshchenko VV; Solovyov A; Madduri D; Chari A; Cho HJ; Dudley JT; Brody JD; Jagannath S; Greenbaum B; Gnjatic S; Bhardwaj N; Parekh S
    Clin Cancer Res; 2020 Jan; 26(2):450-464. PubMed ID: 31857430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.
    Miller A; Asmann Y; Cattaneo L; Braggio E; Keats J; Auclair D; Lonial S; ; Russell SJ; Stewart AK
    Blood Cancer J; 2017 Sep; 7(9):e612. PubMed ID: 28937974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma Models.
    Salomon N; Helm A; Selmi A; Fournier C; Diken M; Schrörs B; Scholz M; Kreiter S; Durante M; Vascotto F
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):936-945. PubMed ID: 38163521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.
    Matsushita H; Hasegawa K; Oda K; Yamamoto S; Nishijima A; Imai Y; Asada K; Ikeda Y; Karasaki T; Fujiwara K; Aburatani H; Kakimi K
    Oncoimmunology; 2017; 6(8):e1338996. PubMed ID: 28920005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens.
    Bekri S; Rodney-Sandy R; Gruenstein D; Mei A; Bogen B; Castle J; Levey D; Cho HJ
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35190376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression.
    Nguyen KB; Roerden M; Copeland CJ; Backlund CM; Klop-Packel NG; Remba T; Kim B; Singh NK; Birnbaum ME; Irvine DJ; Spranger S
    Elife; 2023 Aug; 12():. PubMed ID: 37548358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Splicing and Cancer.
    Wang E; Aifantis I
    Trends Cancer; 2020 Aug; 6(8):631-644. PubMed ID: 32434734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoantigen landscape in metastatic nasopharyngeal carcinoma.
    Lin M; Zhang XL; You R; Yang Q; Zou X; Yu K; Liu YP; Zou RH; Hua YJ; Huang PY; Wang J; Zhao Q; Jiang XB; Tang J; Gu YK; Yu T; He GP; Xie YL; Wang ZQ; Liu T; Chen SY; Zuo ZX; Chen MY
    Theranostics; 2021; 11(13):6427-6444. PubMed ID: 33995666
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
    Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.
    Nejo T; Matsushita H; Karasaki T; Nomura M; Saito K; Tanaka S; Takayanagi S; Hana T; Takahashi S; Kitagawa Y; Koike T; Kobayashi Y; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Narita Y; Nagane M; Ueki K; Nishikawa R; Aburatani H; Mukasa A; Saito N; Kakimi K
    Cancer Immunol Res; 2019 Jul; 7(7):1148-1161. PubMed ID: 31088845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity.
    Wang Y; Xu J; Lan T; Zhou C; Liu P
    Cancer Med; 2023 Dec; 12(24):21651-21665. PubMed ID: 37965778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma.
    Matsushita H; Hasegawa K; Oda K; Yamamoto S; Asada K; Karasaki T; Yabuno A; Nishijima A; Nejo T; Kobayashi Y; Sato S; Ikeda Y; Miyai M; Takahashi Y; Yamaguchi R; Fujiwara K; Aburatani H; Kakimi K
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma.
    Zhang Y; Lin Z; Wan Y; Cai H; Deng L; Li R
    Front Immunol; 2019; 10():2472. PubMed ID: 31749795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes.
    Kriangkum J; Warkentin A; Belch AR; Pilarski LM
    PLoS One; 2013; 8(1):e53469. PubMed ID: 23301075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines.
    Shen L; Zhang J; Lee H; Batista MT; Johnston SA
    Sci Rep; 2019 Oct; 9(1):14184. PubMed ID: 31578439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment.
    Fehlings M; Jhunjhunwala S; Kowanetz M; O'Gorman WE; Hegde PS; Sumatoh H; Lee BH; Nardin A; Becht E; Flynn S; Ballinger M; Newell EW; Yadav M
    J Immunother Cancer; 2019 Sep; 7(1):249. PubMed ID: 31511069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
    Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W
    Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma.
    Wang Y; Jin B; Zhou N; Sun Z; Li J; Chen Q; Wu X; Zhou Y; Shi Y; Lu X; Sang X; Mao Y; Du S; Wang W; Bai C
    Curr Cancer Drug Targets; 2020; 20(11):875-886. PubMed ID: 32957886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.